Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications... Show more
a manufacturer of medical devices, implants and biomaterials
Industry MedicalNursingServices
A.I.dvisor indicates that over the last year, IART has been loosely correlated with CNMD. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if IART jumps, then CNMD could also see price increases.
| Ticker / NAME | Correlation To IART | 1D Price Change % | ||
|---|---|---|---|---|
| IART | 100% | -0.26% | ||
| CNMD - IART | 53% Loosely correlated | +0.17% | ||
| RVTY - IART | 49% Loosely correlated | +2.79% | ||
| MTD - IART | 44% Loosely correlated | +1.01% | ||
| A - IART | 43% Loosely correlated | +2.66% | ||
| AZTA - IART | 43% Loosely correlated | +2.22% | ||
More | ||||
| Ticker / NAME | Correlation To IART | 1D Price Change % |
|---|---|---|
| IART | 100% | -0.26% |
| Health Services category (242 stocks) | -3% Poorly correlated | +0.38% |
| Medical/Nursing Services category (141 stocks) | -4% Poorly correlated | +0.38% |
The 10-day moving average for IART crossed bearishly below the 50-day moving average on August 07, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 16 of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 89%.
The Momentum Indicator moved below the 0 level on August 17, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on IART as a result. In 79 of 96 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 82%.
IART moved below its 50-day moving average on August 17, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IART declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 77%.
The Aroon Indicator for IART entered a downward trend on September 11, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +0.41% 3-day Advance, the price is estimated to grow further. Considering data from situations where IART advanced for three days, in 179 of 288 cases, the price rose further within the following month. The odds of a continued upward trend are 62%.
IART may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron PE Growth Rating for this company is 6 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 48 (best 1 - 100 worst), indicating steady price growth. IART’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 83 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.155) is normal, around the industry mean (10.685). P/E Ratio (66.483) is within average values for comparable stocks, (67.907). Projected Growth (PEG Ratio) (0.669) is also within normal values, averaging (3.653). IART has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.018). P/S Ratio (0.724) is also within normal values, averaging (35.925).
The Tickeron SMR rating for this company is 91 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IART’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.